HTA46 Outcomes of Benefit Assessments of Orphan Drugs Without Orphan Designation in Germany

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1506
https://www.valueinhealthjournal.com/article/S1098-3015(22)03711-1/fulltext
Title : HTA46 Outcomes of Benefit Assessments of Orphan Drugs Without Orphan Designation in Germany
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03711-1&doi=10.1016/j.jval.2022.09.1506
First page :
Section Title :
Open access? : No
Section Order : 11054
Categories :
Tags :
Regions :
ViH Article Tags :